NCT03309865View on ClinicalTrials.gov

Evaluating the Combined Effect of Vedolizumab and Semi-Vegetarian Diet on Ulcerative Colitis.

EARLY_PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 25, 2017

Primary Completion Date

August 31, 2018

Study Completion Date

December 31, 2018

Conditions
Ulcerative ColitisDietary Modification
Interventions
DIETARY_SUPPLEMENT

semi-vegetarian diet

semi-vegetarian dietary intervention: Duration of Therapy: 14 weeks;

DRUG

Vedolizumab Injection

vedolizumab (300mg) IV infusions at week 0, 2, 6, 14; Duration of Therapy: 14 weeks

Trial Locations (1)

32224

Mayo Clinic Florida, Jacksonville

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER